FGFJ Advisory Board
The FGFJ Advisory Board is made up of leading figures from various sectors of Japanese society–government, business, civil society, medicine, and academia–who are actively involved in the work of the FGFJ. The board is co-chaired by two key figures in the Diet: Ichiro Aisawa of the Liberal Democratic Party and Motohisa Furukawa of the Democratic Party of Japan. FGFJ Diet Task Force More than two dozen Diet members from all of the major parties participate in the FGFJ Diet Task Force, which convenes regularly to explore ways to broaden Japan’s role in the fight against communicable diseases and exchange views with leaders from around the world.
Advisory Board
As of February 2024
| Board of Advisors | |
|---|---|
| Yoshiro Mori | Former Prime Minister [Chair Emeritus] |
| Ichiro Aisawa | Member of the House of Representatives (LDP) [Co-Chair] |
| Motohisa Furukawa | Member of the House of Representatives (Democratic Party for the People) [Co-Chair] |
| Isao Kano | President and CEO, Japan Center for International Exchange (JCIE) [Director] |
| Mitsuko Horiuchi | President, Kitakyushu Forum on Asian Women; Professor, Bunkyo Gakuin University; former Assistant Director-General of the International Labour Organization (ILO) |
| Masaki Inaba | Director for Global Health, Africa Japan Forum; Board Delegation Member, Developed Country NGO, the Global Fund (2004-2009) |
| Sachiko Imoto | Senior Vice President, Japan International Cooperation Agency (JICA) |
| Naoki Ito | Deputy Director General, Cabinet Secretariat, Office of Healthcare Policy |
| Aikichi Iwamoto | Director, Department of Research Promotion, Japan Agency for Medical Research and Development |
| Shigeyuki Kano | Director, Department of Tropical Medicine and Malaria, Research Institute, National Center for Global Health and Medicine (NCGM); Member, Technical Review Panel for Malaria, The Global Fund (2017–2021) |
| Mihoko Kashiwakura | Head of East Asia Relations, Global Policy and Advocacy, Bill & Melinda Gates Foundation |
| Seiya Kato | Director, Research Institute of Tuberculosis, Japan Anti Tuberculosis Association |
| Osamu Kunii | CEO and Executive Director, the GHIT Fund |
| Kiyoshi Kurokawa | Chairman, Health and Global Policy Institute; Professor Emeritus, National Graduate Institute for Policy Studies |
| Yoshiro Matsuo | Executive Deputy President and Representative Director, Otsuka Pharmaceutical Co., Ltd. |
| Nobuaki Mito | Managing Executive Officer & Representative Director, President of Health & Crop Sciences Sector, Sumitomo Chemical Co., Ltd. |
| Yoshiko Norimatsu | Assistant General Secretary, Japanese Trade Union Confederation (JTUC-RENGO) |
| Kosuke Okada | Director, International Programs, Japan Anti-Tuberculosis Association |
| Shigeru Omi | Representative, Board of Director, Japan Anti-Tuberculosis Association; Regional Director Emeritus, World Health Organization for the Western Pacific |
| Keiichi Ono | Senior Deputy Minister for Foreign Affairs, Ministry of Foreign Affairs |
| Takako Ohyabu | Chief Global Corporate Affairs Officer, Takeda Pharmaceutical Co., Ltd. |
| Takahiro Shinyo | Trustee, Kwansei Gakuin University; Dean and Professor, Integrated Center for UN and Foreign Affairs Studies; Chairman of the Board, Malaria No More Japan (MNMJ) |
| Yasuhisa Shiozaki | Former Member of the House of Representatives |
| Akira Takakura | President, Confederation of Japan Automobile Worker’s Unions |
| Nozomi Tomita | Senior Assistant Minister for Global Health, Ministry of Health, Labor, and Welfare |
| Koji Tsuruoka | Former Ambassador, Embassy of Japan in the United Kingdom |
| Secretariat | |
| Satoko Itoh | Managing Director and Chief Program Officer, JCIE [Assistant Director] |
